Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 5;10(4):262.
doi: 10.3390/pharmaceutics10040262.

Biodistribution of a Radiolabeled Antibody in Mice as an Approach to Evaluating Antibody Pharmacokinetics

Affiliations

Biodistribution of a Radiolabeled Antibody in Mice as an Approach to Evaluating Antibody Pharmacokinetics

Kevin J H Allen et al. Pharmaceutics. .

Abstract

(1) Background: Monoclonal antibodies are used in the treatment of multiple conditions including cancer, autoimmune disorders, and infectious diseases. One of the initial steps in the selection of an antibody candidate for further pre-clinical development is determining its pharmacokinetics in small animal models. The use of mass spectrometry and other techniques to determine the fate of these antibodies is laborious and expensive. Here we describe a straightforward and highly reproducible methodology for utilizing radiolabeled antibodies for pharmacokinetics studies. (2) Methods: Commercially available bifunctional linker CHXA" and 111Indium radionuclide were used. A melanin-specific chimeric antibody A1 and an isotype matching irrelevant control A2 were conjugated with the CHXA", and then radiolabeled with 111In. The biodistribution was performed at 4 and 24 h time points in melanoma tumor-bearing and healthy C57BL/6 female mice. (3) The biodistribution of the melanin-binding antibody showed the significant uptake in the tumor, which increased with time, and very low uptake in healthy melanin-containing tissues such as the retina of the eye and melanized skin. This biodistribution pattern in healthy tissues was very close to that of the isotype matching control antibody. (4) Conclusions: The biodistribution experiment allows us to assess the pharmacokinetics of both antibodies side by side and to make a conclusion regarding the suitability of specific antibodies for further development.

Keywords: antibodies; biodistribution; mouse models; pharmacokinetics; radiolabeling.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. E. Dadachova is a co-inventor on the patent describing radioimmunotherapy of melanoma.

Figures

Figure 1
Figure 1
Biodistribution of 111In-labeled antibodies Ab1 to melanin and isotype matching irrelevant control Ab2 in C57BL6 mice at 4 and 24 h after IV administration. (A) Ab1 antibody in B16F10 melanoma bearing mice; (B) Ab2 in healthy mice. Blue and orange bars represent 4 and 24 h time points, respectively. The error bars represent the SEM of sample groups of 4–5 mice.

Similar articles

Cited by

References

    1. Hung S.Y., Fu W.M. Drug candidates in clinical trials for Alzheimer’s disease. J. Biomed. Sci. 2017;24:47. doi: 10.1186/s12929-017-0355-7. - DOI - PMC - PubMed
    1. Grierson P., Lim K.H., Amin M. Immunotherapy in gastrointestinal cancers. J. Gastrointest. Oncol. 2017;8:474–484. doi: 10.21037/jgo.2017.05.01. - DOI - PMC - PubMed
    1. Gleason C., Catamero D.D. Immunotherapy in Multiple Myeloma. Semin. Oncol. Nurs. 2017;33:292–298. doi: 10.1016/j.soncn.2017.05.011. - DOI - PubMed
    1. Cong Y., Zhang Z., Zhang S., Hu L., Gu J. Quantitative MS analysis of therapeutic mAbs and their glycosylation for pharmacokinetics study. PROTEOMICS–Clin. Appl. 2016;10:303–314. doi: 10.1002/prca.201500098. - DOI - PubMed
    1. Shadid M., Bowlin S., Bolleddula J. Catabolism of antibody drug conjugates and characterization methods. Bioorg. Med. Chem. 2017;25:2933–2945. doi: 10.1016/j.bmc.2017.04.010. - DOI - PubMed

LinkOut - more resources